Fast Track AWAK
Based on successful human trials in Japan, a WAK wearable PD system using sorbent technology received FDA fast track status this year. With thrice-daily use, the device removed toxins and had no serious adverse events. And, since dialysate is regenerated, dramatically less fluid volume can be used.
Read the full article » | Posted 10-14-2019
Related Articles
- A 2026 James Dyson award is for a PD machine in development Posted 10-22-2026
- Proof of Concept for Silicon Nanopore Membrane Implantable HD Posted 10-05-2026
- AWAK PD To Go Posted 10-05-2026
- The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026

